APTO - Aptose Biosciences Inc.
IEX Last Trade
0.2115
0.000 0.142%
Share volume: 695,807
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.21
-0.01
-0.04%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-14 | 2023-08-10 | 2023-11-09 | 2024-11-09 | 2024-05-14 | 2024-08-08 | 2024-11-09 | |
| Cash flow financing | 50.000 K | 1.104 M | 4.902 M | 854.000 K | 11.847 M | 4.754 M | 10.008 M | |
| Other financing cash flows | 0.000 | 0.000 | 3.000 M | -3.040 M | 3.702 M | -177.000 K | 0.000 | |
| Cash flow | -14.212 M | -14.360 M | 7.319 M | -6.467 M | -1.907 M | 985.000 K | 0.000 | |
| Net income | -13.676 M | -14.129 M | -11.447 M | -11.955 M | -9.640 M | -7.252 M | -6.953 M | |
| Depreciation | 28.000 K | 22.000 K | 20.000 K | 18.000 K | 16.000 K | 8.000 K | 4.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -2.960 M | -1.971 M | 12.953 M | 1.938 M | -1.991 M | 2.009 M | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | -1.000 K | 0.000 | 0.000 | |
| Cash Change | -14.208 M | -14.362 M | 7.320 M | -6.468 M | -1.906 M | 984.000 K | -368.000 K |